You are here

Article info

Article menu

Download PDFPDF

Commentary
Asia’s emergence in cancer immunotherapy: challenges and opportunities

Authors

  • Yan Li Department of Hepatobiliary Surgery, Anhui Provincial Clinical Research Center for Hepatobiliary Diseases, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, National Key Laboratory of Immune responses and Immunotherapy, The First Affiliated Hospital of University of Science and Technology of China (USTC), University of Science and Technology of China, Hefei, Anhui, ChinaInstitute of Immunology, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China PubMed articlesGoogle scholar articles
  • Joe Yeong Institute of Molecular and Cell Biology (IMCB), A * STAR, Singapore PubMed articlesGoogle scholar articles
  • Bernard A Fox Molecular and Tumor Immunology, Earle A Chiles Research Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Cheng Sun Department of Hepatobiliary Surgery, Anhui Provincial Clinical Research Center for Hepatobiliary Diseases, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, National Key Laboratory of Immune responses and Immunotherapy, The First Affiliated Hospital of University of Science and Technology of China (USTC), University of Science and Technology of China, Hefei, Anhui, ChinaInstitute of Immunology, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Cheng Sun; charless{at}ustc.edu.cn
View Full Text

Citation

Li Y, Yeong J, Fox BA, et al
Asia’s emergence in cancer immunotherapy: challenges and opportunities
Journal for ImmunoTherapy of Cancer 2025;13:e011278. doi: 10.1136/jitc-2024-011278

Publication history

  • Accepted April 24, 2025
  • First published May 13, 2025.
Online issue publication 
May 13, 2025

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.